首页> 外文OA文献 >Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer

【2h】

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer

机译：放射性标记的抗前列腺特异性膜抗原（psma）抗体J591对患有转移性去势抵抗性前列腺癌的男性进行骨髓恢复和随后的化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Scott T Tagawa; Naveed Hassan Akhtar; Anastasia eNikolopoulou; Gurveen eKaur; Brian eRobinson; Renee eKahn; Shankar eVallabhajosula; Stanley J Goldsmith; David M Nanus; Neil H Bander;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Review of Lutetium-177-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for the Treatment of Metastatic Castration-resistant Prostate Cancer [J] . Muhammad O. Niaz, Michael Sun, Marigdalia K. Ramirez-Fort, Cureus. . 2020,第2期

机译：综述Lutetium-177-标记的抗前列腺特异性膜抗原单克隆抗体J591用于治疗转移性阉割抗阉割前列腺癌
2. Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer [J] . TagawaS.T., MilowskyM.I., MorrisM., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第18期

机译：lut 177标记的抗前列腺特异性膜抗原单克隆抗体J591在转移性去势抵抗性前列腺癌中的II期研究
3. Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. [J] . Bander NH, Trabulsi EJ, Kostakoglu L, The Journal of Urology . 2003,第5期

机译：用放射性标记的单克隆抗体J591将转移性前列腺癌靶向前列腺特异性膜抗原的胞外域。
4. ~(177)Lu-DOTA-J591 MONOCLONAL ANTIBODY: CHEMISTRY, TOXICITY, DOSIMETRY AND CLINICAL EFFICACY: RIT OF PROSTATE CANCER USING ~(177)LU-J591 ANTI-PSMA ANTIBODY [C] . S.J. GOLDSMITH, S. VALLABHAJOSULA, M.I. MILOWSKY, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：〜（177）Lu-DOTA-J591单克隆抗体：化学，毒性，剂量和临床疗效：使用〜（177）LU-J591抗-PSMA抗体的前列腺癌
5. Imaging prostate cancer: Design, synthesis and biological evaluation of optical and radioactive prostate -specific membrane antigen (PSMA) inhibitors [D] . Dusich, Crystal Leah 2008

机译：影像学前列腺癌：光学和放射性前列腺特异性膜抗原（PSMA）抑制剂的设计，合成和生物学评估
6. Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer [O] . Scott T. Tagawa, Naveed H. Akhtar, Anastasia Nikolopoulou, 2013

机译：放射性标记的抗前列腺特异性膜抗原单克隆抗体J591在转移性去势抵抗性前列腺癌患者中的骨髓恢复及随后的化疗
7. Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer [O] . Scott T. Tagawa, Naveed H. Akhtar, Anastasia Nikolopoulou, 2013

机译：放射性标记的抗前列腺特异性膜抗原单克隆抗体J591在患有转移性去势抵抗性前列腺癌的男性中进行骨髓恢复和后续化疗
8. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High Risk Castrate, Biochemically Relapsed Prostate Cancer. [R] . Tagawa, S. T. 2017

机译：177Lu放射性标记的抗psma单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验。

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer

著录项

引文网络

相似文献

相关主题

期刊订阅